跳至主要内容
临床试验/NCT02060084
NCT02060084已完成4 期

Effect of Early Oral Triple Viable Bifidobacterium Intestinal Flora in Preterm

Wang Hua1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2014年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
60
试验地点
1
主要终点
Intestinal flora

研究概览

简要总结

Gut of newborn preterm is sterile, immediately by the mother and the surrounding environment from microbial colonization. As the effects of diet, intestinal flora is rapidly changed. Preterm children significantly delay in the establishment of normal flora,during hospitalization because of no breastfeeding, use of antibiotics, enteral feeding delay, combat disease and other factors. In this study, hospitalized preterm children for the study, the prospective randomized double-blind controlled study, to find oral intestinal bifidobacteria and lactobacilli and bifidobacteria subspecies composition and distribution, and further show intestinal bacteria in premature children case group.

详细描述

Preterm infants are at high risk of deeding intolerance especially low birth weight infants, Whether oral triple viable Bifidobacterium and early Micro-feeding may improve the symptoms of feeding intolerance.

84 preterm infants BW(birth weight) less than 2.5kg,entered neonatal intensive care unit(NICU) less than 24 hours and meet the Inclusion Criteria of this study will be Randomly divided into three groups, control group、 treatment group1 (Triple viable Bifidobacterium 0.5g bid po)、treatment group2 (Triple viable Bifidobacterium 0.5g bid po and early micro-feeding). treatment period for more than 1 week. For three groups, feeding symptoms,the traits and frequency of stool of 3 days,1 weeks,2 weeks.And the stool flora measured by PCR.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
— 至 24 Hours(Child)
性别
All
接受健康志愿者

入选标准

  • preterm with birth weight <2.5kg

排除标准

  • Gastrointestinal bleeding and NEC,Kidney,liver function abnormal and have Serious congenital malformation

研究组 & 干预措施

a control group

Experimental

a control group : the same dose of luke warm water

干预措施: a control group (Drug)

treatment group

Experimental

treatment group: viable Bifidobacterium 0.5 bid po

干预措施: a probiotic-supplemented group (Drug)

结局指标

主要结局

Intestinal flora

时间窗: up to one week

measure the intestinal flora of three groups and identify the effect of early oral triple viable bifidobacterium for preterm infants

次要结局

  • Feeding intolerance(up to one week)

研究者

发起方
Wang Hua
申办方类型
Industry
责任方
Sponsor Investigator
主要研究者

Wang Hua

Director of pediatric

Kunshan First People's Hospital Affiliated to Jiangsu University

研究点 (1)

Loading locations...

相似试验

Effect of Early Oral Triple Viable Bifidobacterium... | 临床试验